FALP - Fundación Arturo López Pérez

Santiago 7500921

1 studies enrolling now · 3 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, First Line Non-Small Cell Lung Cancer, Gastric Cancer, Gastroesophageal Junction Cancer

Studies at this site

• Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer — Recruiting now
• Avelumab in First-line NSCLC (JAVELIN Lung 100) — Completed
• Avelumab in Non-Small Cell Lung Cancer (JAVELIN Lung 200) — Completed